No increase in ADCP by macrophages in the presence of glycoengineered FcαRI BsAbs (A + B) ADCP of (A) A431 and (B) MC38cEGFR by macrophages in the presence of glycovariants FcαRI BsAbs 0.1 or 1.0 µg/ml after 4 hours. ADCP was normalized to No Ab treatment. Data is presented as mean ± standard deviations (SD); n = 3 per group (*P < 0.05). Two-way ANOVA with Tukey’s multiple-comparison correction was performed. Representative experiments out of three independent experiments are shown.